Maureen Mealy from Johns Hopkins Medicine: New Treatments for Neuromyelitis Optica in the Pipeline

While there are no approved treatments currently for neuromyelitis optica, there is a considerable amount of work being done to help patients with this rare condition in the future.

With several clinical trials underway and development moving ahead quickly Maureen A. Mealy, RN, BSN, MSCN, discussed the developments in the field during the annual meeting of the Consortium of Multiple Sclerosis Centers in Maryland.